The duration and the injection timing of G-CSF are effective in the prevention of neutropenia, incidence of infection and non hematologic toxicity. With the TAC chemotherapy after resection of breast cancer, the G-CSF early injection versus late injection could change the frequency of neutropenia.
Age
20–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
primary invasive breast carcinoma with lymph node positive with curative surgery with TAC chemotherapy
You may not be if
pregnancy,
cardiovascualr disease,
abnormal renal function,
hematologic disorder
Clareo Health | Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy
